These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 15994854)

  • 21. The N-terminal region of troponin T is essential for the maximal activation of rat cardiac myofilaments.
    Chandra M; Montgomery DE; Kim JJ; Solaro RJ
    J Mol Cell Cardiol; 1999 Apr; 31(4):867-80. PubMed ID: 10329214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Troponin T modulates sarcomere length-dependent recruitment of cross-bridges in cardiac muscle.
    Chandra M; Tschirgi ML; Rajapakse I; Campbell KB
    Biophys J; 2006 Apr; 90(8):2867-76. PubMed ID: 16443664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiomyopathy-related mutation (A30V) in mouse cardiac troponin T divergently alters the magnitude of stretch activation in α- and β-myosin heavy chain fibers.
    Mickelson AV; Gollapudi SK; Chandra M
    Am J Physiol Heart Circ Physiol; 2017 Jan; 312(1):H141-H149. PubMed ID: 27769999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interplay between the overlapping ends of tropomyosin and the N terminus of cardiac troponin T affects tropomyosin states on actin.
    Mamidi R; Michael JJ; Muthuchamy M; Chandra M
    FASEB J; 2013 Sep; 27(9):3848-59. PubMed ID: 23748972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Caffeine alters cardiac myofilament activity and regulation independently of Ca2+ binding to troponin C.
    Powers FM; Solaro RJ
    Am J Physiol; 1995 Jun; 268(6 Pt 1):C1348-53. PubMed ID: 7611352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An alpha-cardiac myosin heavy chain gene mutation impairs contraction and relaxation function of cardiac myocytes.
    Kim SJ; Iizuka K; Kelly RA; Geng YJ; Bishop SP; Yang G; Kudej A; McConnell BK; Seidman CE; Seidman JG; Vatner SF
    Am J Physiol; 1999 May; 276(5):H1780-7. PubMed ID: 10330263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential effect of troponin T mutations on the inotropic responsiveness of mouse hearts--role of myofilament Ca2+ sensitivity increase.
    Sirenko SG; Potter JD; Knollmann BC
    J Physiol; 2006 Aug; 575(Pt 1):201-13. PubMed ID: 16777946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Malignant familial hypertrophic cardiomyopathy D166V mutation in the ventricular myosin regulatory light chain causes profound effects in skinned and intact papillary muscle fibers from transgenic mice.
    Kerrick WG; Kazmierczak K; Xu Y; Wang Y; Szczesna-Cordary D
    FASEB J; 2009 Mar; 23(3):855-65. PubMed ID: 18987303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathogenesis of Hypertrophic Cardiomyopathy is Mutation Rather Than Disease Specific: A Comparison of the Cardiac Troponin T E163R and R92Q Mouse Models.
    Ferrantini C; Coppini R; Pioner JM; Gentile F; Tosi B; Mazzoni L; Scellini B; Piroddi N; Laurino A; Santini L; Spinelli V; Sacconi L; De Tombe P; Moore R; Tardiff J; Mugelli A; Olivotto I; Cerbai E; Tesi C; Poggesi C
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28735292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered signaling surrounding the C-lobe of cardiac troponin C in myofilaments containing an alpha-tropomyosin mutation linked to familial hypertrophic cardiomyopathy.
    Burkart EM; Arteaga GM; Sumandea MP; Prabhakar R; Wieczorek DF; Solaro RJ
    J Mol Cell Cardiol; 2003 Oct; 35(10):1285-93. PubMed ID: 14519438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of cardiac troponin T with COOH-terminal truncation accelerates cross-bridge interaction kinetics in mouse myocardium.
    Stelzer JE; Patel JR; Olsson MC; Fitzsimons DP; Leinwand LA; Moss RL
    Am J Physiol Heart Circ Physiol; 2004 Oct; 287(4):H1756-61. PubMed ID: 15165990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypertrophic cardiomyopathy associated E22K mutation in myosin regulatory light chain decreases calcium-activated tension and stiffness and reduces myofilament Ca
    Zhang J; Wang L; Kazmierczak K; Yun H; Szczesna-Cordary D; Kawai M
    FEBS J; 2021 Aug; 288(15):4596-4613. PubMed ID: 33548158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac-specific overexpression of sarcolipin inhibits sarco(endo)plasmic reticulum Ca2+ ATPase (SERCA2a) activity and impairs cardiac function in mice.
    Asahi M; Otsu K; Nakayama H; Hikoso S; Takeda T; Gramolini AO; Trivieri MG; Oudit GY; Morita T; Kusakari Y; Hirano S; Hongo K; Hirotani S; Yamaguchi O; Peterson A; Backx PH; Kurihara S; Hori M; MacLennan DH
    Proc Natl Acad Sci U S A; 2004 Jun; 101(25):9199-204. PubMed ID: 15201433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of a mutant (Arg92Gln) human cardiac troponin T, known to cause hypertrophic cardiomyopathy, impairs adult cardiac myocyte contractility.
    Marian AJ; Zhao G; Seta Y; Roberts R; Yu QT
    Circ Res; 1997 Jul; 81(1):76-85. PubMed ID: 9201030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell-specific promoter in adenovirus vector for transgenic expression of SERCA1 ATPase in cardiac myocytes.
    Inesi G; Lewis D; Sumbilla C; Nandi A; Strock C; Huff KW; Rogers TB; Johns DC; Kessler PD; Ordahl CP
    Am J Physiol; 1998 Mar; 274(3):C645-53. PubMed ID: 9530095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of Sarcomere Activators and Inhibitors Targeting Myosin Cross-Bridges on Ca
    Halas M; Langa P; Warren CM; Goldspink PH; Wolska BM; Solaro RJ
    Mol Pharmacol; 2022 May; 101(5):286-299. PubMed ID: 35236770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transgenic incorporation of skeletal TnT into cardiac myofilaments blunts PKC-mediated depression of force.
    Montgomery DE; Chandra M; Huang Q; Jin J; Solaro RJ
    Am J Physiol Heart Circ Physiol; 2001 Mar; 280(3):H1011-8. PubMed ID: 11179042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Familial hypertrophic cardiomyopathy-linked mutant troponin T causes stress-induced ventricular tachycardia and Ca2+-dependent action potential remodeling.
    Knollmann BC; Kirchhof P; Sirenko SG; Degen H; Greene AE; Schober T; Mackow JC; Fabritz L; Potter JD; Morad M
    Circ Res; 2003 Mar; 92(4):428-36. PubMed ID: 12600890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced myocardial contractility and increased Ca2+ transport function in transgenic hearts expressing the fast-twitch skeletal muscle sarcoplasmic reticulum Ca2+-ATPase.
    Loukianov E; Ji Y; Grupp IL; Kirkpatrick DL; Baker DL; Loukianova T; Grupp G; Lytton J; Walsh RA; Periasamy M
    Circ Res; 1998 Nov; 83(9):889-97. PubMed ID: 9797337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alterations of tension-dependent ATP utilization in a transgenic rat model of hypertrophic cardiomyopathy.
    Frey N; Brixius K; Schwinger RH; Benis T; Karpowski A; Lorenzen HP; Luedde M; Katus HA; Franz WM
    J Biol Chem; 2006 Oct; 281(40):29575-82. PubMed ID: 16882671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.